LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.
about
Oligodendrogenesis in the normal and pathological central nervous systemOligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and UpdateRemyelination therapy for multiple sclerosisNogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasmAntibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating DiseaseIncreased LINGO1 in the cerebellum of essential tremor patients.Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.The potential of LINGO-1 as a therapeutic target for essential tremor.Activation of endogenous neural stem cells for multiple sclerosis therapy.Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signallingLINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.The axon-glia unit in white matter stroke: mechanisms of damage and recovery.Development of a central nervous system axonal myelination assay for high throughput screening.Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditionsSingle-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomasAPP Receptor? To Be or Not To Be.Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives.Myelin-based inhibitors of oligodendrocyte myelination: clues from axonal growth and regeneration.Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.Multiple sclerosis: does Nogo play a role?Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.New Insights into the Roles of Nogo-A in CNS Biology and Diseases.Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationLeukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.Lingo-1 inhibited by RNA interference promotes functional recovery of experimental autoimmune encephalomyelitis.Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains.The Rules of Attraction in Central Nervous System Myelination
P2860
Q21129352-D83C5820-4AA4-4D7D-ABB1-F01BB907C90BQ26780518-E9FA9211-7456-431A-BB88-4F6E546B5B5AQ26824246-7EA3C5F2-835D-4377-B332-2D9A47978F6CQ27313149-AC8C0430-19E0-412F-84C5-93C394543CCFQ28080515-DC743AAD-8AC6-4C9F-88D7-79713F41E22FQ34039911-4E2FB6AE-8854-4D23-AF35-921EB5220C9BQ34172960-8AFA1BE1-B4EF-4F14-A8B2-654FB81E6927Q34471202-9C9B3371-C39C-408D-BFBF-B3EFB7B773D6Q34986269-3B8D548B-D09D-47B5-BFB8-FFE5EE342C3BQ34994532-AC68D785-B131-42D1-84AB-76CFDB97BA93Q35351651-BDA0446C-6C5E-419C-AF2A-E71123EE5BA0Q35984483-0E577A50-3CB0-46D1-A246-0F564D6656A8Q35996695-286FFABB-C23C-4CFD-BCCB-085BEF49B1E9Q36090107-25377096-F553-4D97-9084-463F748E4DE9Q36122722-727E6E07-7094-479B-A4D3-4C83355CBEE1Q36133389-E22D77A5-3EEC-4B8F-A3B1-9737BBF1123CQ36204396-2D4EE7AB-6486-4F8D-A64E-9EFE4352DDB0Q36840033-8D230BD4-9BE1-4E2F-97EE-E068F1A4EE97Q37144056-30D649E0-7AF4-4E8F-86AE-57972CF5D1D7Q37537088-F44D3F64-F7CB-44AC-8076-00ABA716F1BCQ37705505-8A0396CA-3C20-4358-8B07-B619ABDEE6A3Q38082999-31CBF731-C305-4ABF-8DC8-62F1DA6AD737Q38108182-51C84588-E5D8-4AED-8A06-24CDACCBEA95Q38565299-9D5A5604-618A-470D-9498-7C2C698A2703Q38677868-328C2A43-CF7A-434F-9172-EA8DF3F07E93Q38789322-2EAB5988-1F0A-49A7-B22D-8E576C40F294Q39389823-EFC9107E-8620-45D5-A7CE-49D58C86B0A1Q41855417-45DAE2EA-B80C-4E2F-A63B-2ABA51D4D0B7Q42149118-27345250-05A4-4583-B168-08617087DA7DQ42204878-A1B64AAC-7092-44F6-AE64-6B9A0CF0F7ECQ46272160-7EC2708C-77A7-43B8-B588-FB7C200FEB10Q58122009-9DB9F64B-4294-4955-9894-B58E3B9EE7F7
P2860
LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@ast
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@en
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@nl
type
label
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@ast
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@en
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@nl
prefLabel
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@ast
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@en
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@nl
P2093
P2860
P356
P1476
LINGO-1, a transmembrane signa ...... tercellular self-interactions.
@en
P2093
Bryan Vought
Christian H Gross
Derek Lowe
Douglas Austen
J Daniel Frantz
Jacque Zwahlen
Raul Krauss
Scott Jepson
William Markland
P2860
P304
22184-22195
P356
10.1074/JBC.M112.366179
P407
P577
2012-04-18T00:00:00Z